GSK makes clean sweep of HGS executive suite; Knode wins Big Pharma client;

Conversations on Twitter :

 @FierceBiotech: RIP: After long illness, Genta finally opts to liquidate. News | Follow @FierceBiotech

 @JohnCFierce: Bristol's bad, awful, not very good day. Pensions exec charged with insider trading, via Bloomberg. And it's still early. More | Follow @JohnCFierce

 @RyanMFierce: A Google search for scientific experts? AstraZeneca adopts search engine for scientists from David Steinberg's Knode. Article | Follow @RyanMFierce

> GlaxoSmithKline wasted no time pussyfooting around Human Genome Sciences, now that it owns the place. Glaxo swept into its newly acquired company and swept out almost all of its leadership. GSK ($GSK) veterans are taking the top three executive spots at HGS, The Washington Post reports. Deirdre Connelly will take the helm as president and CEO, replacing H. Thomas Watkins, who's been running the company since 2004. Connelly has been running Glaxo's North American pharma business. Story

> London-based drug giant AstraZeneca ($AZN) has headlined a group of early users of Boston-based startup Knode's search engine of sorts for finding life sciences experts and their digital content, becoming the first Big Pharma revealed as an adopter of the web-based software. Story

> Hemispherx ($HEB) says it has filed a response to the FDA's 2009 CRL on its NDA for Ampligen to treat chronic fatigue syndrome. Release

> Map Pharmaceuticals ($MAPP) is raising $52 million to market its migraine drug after a hoped-for approval. Story

Pharma News

 @FiercePharma: Watson got FDA nod for its Pulmicort knockoff. Patent fight with AstraZeneca pending, so no launch yet. Report | Follow @FiercePharma

> Gilead inks low-cost HIV drug deal with generics makers. News

> Sanofi, Otsuka amp up their Turkish ambitions. Story

> Glass Lewis stands up for Forest's board slate. Article

Medical Device News

@FierceMedDev: The $3.8B deal is done. Hologic wrapped up its bid to acquire Gen-Probe. Release | Follow @FierceMedDev

 @MarkHFierce: Regulators in Singapore lowered import fees for blood pressure monitors and hearing aids. More | Follow @MarkHFierce

 @DamianFierce: Covidien has opened up its $45M R&D shop in Shanghai. News | Follow @DamianFierce

> CareFusion hit with Class I recall of infusion pump component. News

> Becton, Dickinson trims expectations after Q3 loss. More

Vaccines News

> Old whooping cough vax more effective than new. News

> AstraZeneca wins Fluenz contract in U.K. Article

> Survey: U.S. females fail to finish Merck and GSK HPV shots. More

> NIH awards $5M for heroin addiction, AIDS vaccine. News

> Alnylam gets $3.2M milestone from GSK for vax tech. Story

Pharma Manufacturing News 

> Hospira CEO Ball says it's getting 'gators' under control. Report

> Rexam eyes factory growth, despite lagging healthcare sales. More

> CMC nabs Xoma's Bay Area plant. Article

And Finally… New research indicates that coffee may help Parkinson's patients to control their movements. Release

 

Suggested Articles

Passage Bio filed to raise $125 million in its IPO. Now, it has outraised that goal by $91 million with a $216 million Wall Street debut.

The ruling reflects the judge’s belief that the FDA’s interpretation of the law on clinical trial reporting “is unlawful and must be set aside.”

Trutino will apply a platform designed to yield safer, more effective cytokines to the discovery of three oncology drugs for Boehringer.